Effects of imipenem and meropenem on purine content of endothelial cells

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 2, 1999, Pages 86-89

  Armbruster, C ^a   Vorbach, H ^a   Robibaro, B ^b   Schaumann, R ^c   Buxbaum, A ^c   Reiter, M ^c   Georgopoulos, A ^c  

^a Pulmologisches Zentrum   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelial cells; Imipenem; Meropenem; Purines

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; DNA; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; IMIPENEM; MEROPENEM; PURINE; RNA;

ARTICLE; CELL ENERGY; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENDOTHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; RNA SYNTHESIS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; HUMANS; IMIPENEM; PURINES; THIENAMYCINS; UMBILICAL VEINS;

EID: 0033043947     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Burgmann H, Georgopoulos A, Graninger W, Koppensteiner R, Maca T, Minar E, Schneider B, Stümpfler A, Ehringer H 1996 Tissue concentration of clindamycin and gentamycin near ischaemic ulcers with transvenous injection in Bier's arterial arrest. Lancet 348: 781-783
2. Forgue ST, Shyu WC, Gleason CR, Pittman KA, Barbaiyȧ RH 1987 Pharmacokinetics of the novel cephalosporin cefepime (BMY-28142) in rats and monkeys. Antimicrob Agents Chemother 31: 799-804
3. Griesmacher A, Weigel G, Seebach G, Mueller MM 1997 IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide. Clin Chem 43: 2312-2317
4. Haudenschild CC, Cotran RS, Gimbrone MA, Folkman J 1975 Fine structure of vascular endothelium in culture. J Ultrastruct Res 50: 22-34
5. Jaffe EA, Hoyer LW, Nachman RL 1973 Synthesis of antihaemophilic factor antigen by human endothelial cells. J Clin Invest 52: 2757-2763
6. Jaffe EA, Nachman RL, Becker CG, Minck CR 1973 Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52: 2745-2756
7. Robibaro B, Vorbach H, Weigel G, Weihs A, Hlousek M, Presterl E, Georgopous A, Griesmacher A, Graninger W 1998 Endothelial cell compatibility of glycopeptide antibiotics for intravenous use. J Antimicrob Chemother 41: 297-300
8. Vilusksela M, Vainio PJ, Tuominen RK 1996 Cytotoxicity of macrolide antibiotics in a cultured human liver cell line. J Antimicrob Chemother 38: 465-473
9. Vorbach H, Weigel G, Robibaro B, Schaumann R, Hlousek M, Beil WJ, Griesmacher A, Georgopouhs A, Graninger W 1997 Endothelial cell compatibility of fluoroquinolone solutions for intravenous use. Int J Clin Pharmacol Ther 35: 235-238
10. Weigel G, Griesmacher A, Toma C, Leukauf C, Schreiner W, Wolner E 1993 The protective potency of two commonly used cardioplegic solutions on cultured endothelial cells exposed to free oxygen radicals injury. Free Radical Biol Med 17: 577-585
11. Wiseman LR, Wagstaff AJ, Brogden RN, Bryson HM 1995 Meropenem: A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 50: 73-101